Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis

Launched by IRCCS BURLO GAROFOLO · Aug 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying Juvenile Idiopathic Arthritis (JIA), which is a type of arthritis that affects children and can cause joint pain and swelling. The goal of the trial is to find better ways to classify and treat JIA by using new methods, like special ultrasound tests, to see the condition of the joints more clearly. This could help doctors create personalized treatment plans that are more effective for each child based on their specific type of arthritis.

To be eligible for the trial, participants must be under 18 years old and have arthritis that has lasted for at least 6 weeks without a known cause. Unfortunately, children with certain other types of arthritis or those who do not have permission from their guardians cannot participate. If enrolled, participants will undergo evaluations that will help doctors understand their condition better and potentially improve future treatments for JIA. This trial is currently enrolling participants, and it aims to make a real difference in how we understand and manage this childhood disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects under the age of 18 years
• • Arthritis persisting for at least 6 weeks with no known cause
• Exclusion Criteria:
• • No consent from the patients' guardians
• • Patients with Systemic onset Juvenile Idiopathic Arthritis
• • Patients who developed arthritis on a pre-existing inflammatory disorder such as Inflammatory Bowel Disease, and had received previous treatments